trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Hypertension, Pulmonary D006976 32 associated lipids
Endometriosis D004715 29 associated lipids
Uterine Neoplasms D014594 18 associated lipids
Adrenoleukodystrophy D000326 29 associated lipids
Prostatic Hyperplasia D011470 20 associated lipids
Alzheimer Disease D000544 76 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Leukemia D007938 74 associated lipids
Neuroblastoma D009447 66 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
McBlane F and Boyes J Stimulation of V(D)J recombination by histone acetylation. 2000 Curr. Biol. pmid:10801420
Hobbs CA and Gilmour SK High levels of intracellular polyamines promote histone acetyltransferase activity resulting in chromatin hyperacetylation. 2000 J. Cell. Biochem. pmid:10760944
Yoshida M and Horinouchi S [Histone deacetylase inhibitors--new anticancer agents?]. 2000 Tanpakushitsu Kakusan Koso pmid:10771678
Yu F et al. Histone deacetylase-independent transcriptional repression by methyl-CpG-binding protein 2. 2000 Nucleic Acids Res. pmid:10773092
Kitamura K et al. Histone deacetylase inhibitor but not arsenic trioxide differentiates acute promyelocytic leukaemia cells with t(11;17) in combination with all-trans retinoic acid. 2000 Br. J. Haematol. pmid:10792271
Saleh M et al. Cell signaling switches HOX-PBX complexes from repressors to activators of transcription mediated by histone deacetylases and histone acetyltransferases. 2000 Mol. Cell. Biol. pmid:11046157
Andoh A et al. Modulation of complement component (C3 and factor B) biosynthesis by a histone deacetylase inhibitor in human intestinal epithelial cells. 2000 Int. J. Mol. Med. pmid:10851266
Siavoshian S et al. Butyrate and trichostatin A effects on the proliferation/differentiation of human intestinal epithelial cells: induction of cyclin D3 and p21 expression. 2000 Gut pmid:10716680
Jin S et al. Ecteinascidin 743, a transcription-targeted chemotherapeutic that inhibits MDR1 activation. 2000 Proc. Natl. Acad. Sci. U.S.A. pmid:10841572
Claassen GF and Hann SR A role for transcriptional repression of p21CIP1 by c-Myc in overcoming transforming growth factor beta -induced cell-cycle arrest. 2000 Proc. Natl. Acad. Sci. U.S.A. pmid:10920185
Mao C and Shapiro DJ A histone deacetylase inhibitor potentiates estrogen receptor activation of a stably integrated vitellogenin promoter in HepG2 cells. 2000 Endocrinology pmid:10875235
Clayton AL et al. Phosphoacetylation of histone H3 on c-fos- and c-jun-associated nucleosomes upon gene activation. 2000 EMBO J. pmid:10899125
Kang J et al. Heat shock protein 90 mediates protein-protein interactions between human aminoacyl-tRNA synthetases. 2000 J. Biol. Chem. pmid:10913161
Yu J et al. Transcriptional repression by blimp-1 (PRDI-BF1) involves recruitment of histone deacetylase. 2000 Mol. Cell. Biol. pmid:10713181
Adachi N et al. Cell-cycle regulation of the DNA topoisomerase IIalpha promoter is mediated by proximal CCAAT boxes: possible involvement of acetylation. 2000 Gene pmid:10713444
Shin JY et al. Mechanism for inactivation of the KIP family cyclin-dependent kinase inhibitor genes in gastric cancer cells. 2000 Cancer Res. pmid:10667572
Hodny Z et al. Sp1 and chromatin environment are important contributors to the formation of repressive chromatin structures on the transfected human adenine nucleotide translocase-2 promoter. 2000 Biochem. J. pmid:10657244
Garrison PM et al. Effects of histone deacetylase inhibitors on the Ah receptor gene promoter. 2000 Arch. Biochem. Biophys. pmid:10666294
Smith RD et al. Quantitative PCR analysis of HbF inducers in primary human adult erythroid cells. 2000 Blood pmid:10648397
Nakayama T et al. Epigenetic regulation of androgen receptor gene expression in human prostate cancers. 2000 Lab. Invest. pmid:11140692
Fukuda K Apoptosis-associated cleavage of beta-catenin in human colon cancer and rat hepatoma cells. 1999 Mar-Apr Int. J. Biochem. Cell Biol. pmid:10224675
Schmidt K et al. Inhibitors of histone deacetylase suppress the growth of MCF-7 breast cancer cells. 1999 Arch. Pharm. (Weinheim) pmid:10575368
Jung M et al. Amide analogues of trichostatin A as inhibitors of histone deacetylase and inducers of terminal cell differentiation. 1999 J. Med. Chem. pmid:10579829
Chien PY et al. A fusion protein of the estrogen receptor (ER) and nuclear receptor corepressor (NCoR) strongly inhibits estrogen-dependent responses in breast cancer cells. 1999 Mol. Endocrinol. pmid:10598586
Taddei A et al. Duplication and maintenance of heterochromatin domains. 1999 J. Cell Biol. pmid:10601331
Sowa Y et al. Histone deacetylase inhibitor activates the p21/WAF1/Cip1 gene promoter through the Sp1 sites. 1999 Ann. N. Y. Acad. Sci. pmid:10667218
Kim YB et al. Selective induction of cyclin-dependent kinase inhibitors and their roles in cell cycle arrest caused by trichostatin A, an inhibitor of histone deacetylase. 1999 Ann. N. Y. Acad. Sci. pmid:10667219
Marenzi S et al. Efficiency of expression of transfected genes depends on the cell cycle. 1999 Mol. Biol. Rep. pmid:10634509
Gray SG et al. IGF-II enhances trichostatin A-induced TGFbeta1 and p21(Waf1,Cip1, sdi1) expression in Hep3B cells. 1999 Exp. Cell Res. pmid:10585285
Saunders N et al. Histone deacetylase inhibitors as potential anti-skin cancer agents. 1999 Cancer Res. pmid:9927053
O'Neill LP et al. A developmental switch in H4 acetylation upstream of Xist plays a role in X chromosome inactivation. 1999 EMBO J. pmid:10329635
Strouboulis J et al. Transcriptional repression by XPc1, a new Polycomb homolog in Xenopus laevis embryos, is independent of histone deacetylase. 1999 Mol. Cell. Biol. pmid:10330136
Condreay JP et al. Transient and stable gene expression in mammalian cells transduced with a recombinant baculovirus vector. 1999 Proc. Natl. Acad. Sci. U.S.A. pmid:9874783
Cameron EE et al. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. 1999 Nat. Genet. pmid:9916800
Ghosh AK et al. MBP-1 physically associates with histone deacetylase for transcriptional repression. 1999 Biochem. Biophys. Res. Commun. pmid:10403782
Gradin K et al. Repression of dioxin signal transduction in fibroblasts. Identification Of a putative repressor associated with Arnt. 1999 J. Biol. Chem. pmid:10224119
Kim YB et al. Oxamflatin is a novel antitumor compound that inhibits mammalian histone deacetylase. 1999 Oncogene pmid:10229197
Johnson BS et al. Retinoid X receptor (RXR) agonist-induced activation of dominant-negative RXR-retinoic acid receptor alpha403 heterodimers is developmentally regulated during myeloid differentiation. 1999 Mol. Cell. Biol. pmid:10207061
Niki T et al. A histone deacetylase inhibitor, trichostatin A, suppresses myofibroblastic differentiation of rat hepatic stellate cells in primary culture. 1999 Hepatology pmid:10051490
Hasegawa T et al. Cloning of a GADD34-like gene that interacts with the zinc-finger transcription factor which binds to the p21(WAF) promoter. 1999 Biochem. Biophys. Res. Commun. pmid:10066455
Inokoshi J et al. Neuronal differentiation of neuro 2a cells by inhibitors of cell cycle progression, trichostatin A and butyrolactone I. 1999 Biochem. Biophys. Res. Commun. pmid:10079191
Olsson TG et al. Transient inhibition of histone deacetylase activity overcomes silencing in the mating-type region in fission yeast. 1999 Curr. Genet. pmid:10079326
Liu Z et al. Steroid receptor coactivator-1 (SRC-1) enhances ligand-dependent and receptor-dependent cell-free transcription of chromatin. 1999 Proc. Natl. Acad. Sci. U.S.A. pmid:10449719
Wang J et al. Inhibitors of histone deacetylase relieve ETO-mediated repression and induce differentiation of AML1-ETO leukemia cells. 1999 Cancer Res. pmid:10383127
Suzuki T et al. Synthesis and histone deacetylase inhibitory activity of new benzamide derivatives. 1999 J. Med. Chem. pmid:10425110
Tagami T et al. Mechanisms that mediate negative regulation of the thyroid-stimulating hormone alpha gene by the thyroid hormone receptor. 1999 J. Biol. Chem. pmid:10428804
Radkov SA et al. Epstein-Barr virus nuclear antigen 3C interacts with histone deacetylase to repress transcription. 1999 J. Virol. pmid:10364319
Croft JA et al. Differences in the localization and morphology of chromosomes in the human nucleus. 1999 J. Cell Biol. pmid:10366586
Criqui-Filipe P et al. Net, a negative Ras-switchable TCF, contains a second inhibition domain, the CID, that mediates repression through interactions with CtBP and de-acetylation. 1999 EMBO J. pmid:10369679
Zhao W et al. Trichostatin A up-regulates human papillomavirus type 11 upstream regulatory region-E6 promoter activity in undifferentiated primary human keratinocytes. 1999 J. Virol. pmid:10233965